RELMARQA
LIVE

Serial Number

98858243

Owner

Corcept Therapeutics Incorporated

Attorney

Joel R. Feldman

Filing Date

Nov 18, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RELMARQA Trademark

Serial Number: 98858243

RELMARQA is a trademark filed by Corcept Therapeutics Incorporated on November 18, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Corcept Therapeutics Incorporated (3 trademarks)

101 Redwood Shores Parkway, 3rd Floor
Redwood City, CA 94065

Entity Type: 03

Trademark Details

Filing Date

November 18, 2024

Registration Date

Not Registered

Published for Opposition

April 29, 2025

Goods & Services

Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 29, 2026 EXRA
SOU EXTENSION 2 GRANTED
May 28, 2026 EX2G
SOU EXTENSION 2 FILED
May 28, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
May 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 21, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 19, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 19, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 19, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 24, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 31, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2024 NWOS
NEW APPLICATION ENTERED
Nov 18, 2024 NWAP